Literature DB >> 11533159

Antigenically distinct conformations of CXCR4.

F Baribaud1, T G Edwards, M Sharron, A Brelot, N Heveker, K Price, F Mortari, M Alizon, M Tsang, R W Doms.   

Abstract

The major human immunodeficiency virus type 1 (HIV-1) coreceptors are the chemokine receptors CCR5 and CXCR4. The patterns of expression of the major coreceptors and their use by HIV-1 strains largely explain viral tropism at the level of entry. However, while virus infection is dependent upon the presence of CD4 and an appropriate coreceptor, it can be influenced by a number of factors, including receptor concentration, affinity between envelope gp120 and receptors, and potentially receptor conformation. Indeed, seven-transmembrane domain receptors, such as CCR5, can exhibit conformational heterogeneity, although the significance for virus infection is uncertain. Using a panel of monoclonal antibodies (MAbs) to CXCR4, we found that CXCR4 on both primary and transformed T cells as well as on primary B cells exhibited considerable conformational heterogeneity. The conformational heterogeneity of CXCR4 explains the cell-type-dependent ability of CXCR4 antibodies to block chemotaxis to stromal cell-derived factor 1 alpha and to inhibit HIV-1 infection. In addition, the MAb most commonly used to study CXCR4 expression, 12G5, recognizes only a subpopulation of CXCR4 molecules on all primary cell types analyzed. As a result, CXCR4 concentrations on these important cell types have been underestimated to date. Finally, while the factors responsible for altering CXCR4 conformation are not known, we found that they do not involve CXCR4 glycosylation, sulfation of the N-terminal domain of CXCR4, or pertussis toxin-sensitive G-protein coupling. The fact that this important HIV-1 coreceptor exists in multiple conformations could have implications for viral entry and for the development of receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533159      PMCID: PMC114464          DOI: 10.1128/JVI.75.19.8957-8967.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.

Authors:  T Dragic; A Trkola; D A Thompson; E G Cormier; F A Kajumo; E Maxwell; S W Lin; W Ying; S O Smith; T P Sakmar; J P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.

Authors:  A Brelot; N Heveker; M Montes; M Alizon
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

3.  G-protein diseases furnish a model for the turn-on switch.

Authors:  T Iiri; Z Farfel; H R Bourne
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

4.  SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells.

Authors:  M Honczarenko; R S Douglas; C Mathias; B Lee; M Z Ratajczak; L E Silberstein
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

5.  Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes.

Authors:  M Sharron; S Pöhlmann; K Price; E Lolis; M Tsang; F Kirchhoff; R W Doms; B Lee
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

6.  Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.

Authors:  X Xiao; D Norwood; Y R Feng; M Moriuchi; A Jones-Trower; T S Stantchev; H Moriuchi; C C Broder; D S Dimitrov
Journal:  Exp Mol Pathol       Date:  2000-06       Impact factor: 3.362

7.  Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.

Authors:  S E Kuhmann; E J Platt; S L Kozak; D Kabat
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.

Authors:  Q H Liu; D A Williams; C McManus; F Baribaud; R W Doms; D Schols; E De Clercq; M I Kotlikoff; R G Collman; B D Freedman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

9.  Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes.

Authors:  B Tilton; L Ho; E Oberlin; P Loetscher; F Baleux; I Clark-Lewis; M Thelen
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

10.  HIV-1 membrane fusion: targets of opportunity.

Authors:  R W Doms; J P Moore
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  62 in total

1.  Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection.

Authors:  Brian J Willett; Celia A Cannon; Margaret J Hosie
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.

Authors:  Sven Jähnichen; Christophe Blanchetot; David Maussang; Maria Gonzalez-Pajuelo; Ken Y Chow; Leontien Bosch; Sindi De Vrieze; Benedikte Serruys; Hans Ulrichts; Wesly Vandevelde; Michael Saunders; Hans J De Haard; Dominique Schols; Rob Leurs; Peter Vanlandschoot; Theo Verrips; Martine J Smit
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 4.  Therapeutic antibodies directed at G protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; Fiona H Marshall
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

5.  The HIV-1 coat protein gp120 regulates CXCR4-mediated signaling in neural progenitor cells.

Authors:  Phuong B Tran; Dongjun Ren; Richard J Miller
Journal:  J Neuroimmunol       Date:  2004-12-28       Impact factor: 3.478

6.  Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.

Authors:  Andrii Ishchenko; Daniel Wacker; Mili Kapoor; Ai Zhang; Gye Won Han; Shibom Basu; Nilkanth Patel; Marc Messerschmidt; Uwe Weierstall; Wei Liu; Vsevolod Katritch; Bryan L Roth; Raymond C Stevens; Vadim Cherezov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

7.  Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression.

Authors:  Scott N Byrne; Alberto Y Limón-Flores; Stephen E Ullrich
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 8.  Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.

Authors:  T R Nayak; H Hong; Y Zhang; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 9.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

10.  Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4.

Authors:  Yutaka Kofuku; Chie Yoshiura; Takumi Ueda; Hiroaki Terasawa; Takahiro Hirai; Sae Tominaga; Masako Hirose; Yoshitake Maeda; Hideo Takahashi; Yuya Terashima; Kouji Matsushima; Ichio Shimada
Journal:  J Biol Chem       Date:  2009-10-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.